Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Cost-Effectiveness Analysis of Vaccination against Rotavirus with RIX4414 in France
Applied Health Economics and Health Policy, 04/30/09
Standaert B et al. - The results demonstrate that a generalized vaccination strategy with RIX4414 would be cost effective in France from a limited societal perspective, depending on the baseline assumptions for disease progression and on utility scores selected.
Related Articles
Economic evaluation of arthritis self management in primary care
British Medical Journal, 10/08/09
Relevance Score: 87%
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis
Internal and Emergency Medicine, 11/10/09
Relevance Score: 84%
Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis
British Medical Journal, 10/08/09
Relevance Score: 84%
Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09
Relevance Score: 84%
Fine-needle aspiration of primary osseous lesions: A cost effectiveness study
Diagnostic Cytopathology, 10/06/09
Relevance Score: 84%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
California to receive federal matching funds for electronic health record incentives program
Centers for Medicare & Medicaid Services Press, 12/18/09
Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09
HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


